Allergy Asthma Respir Dis.  2014 Nov;2(5):391-393. 10.4168/aard.2014.2.5.391.

Chronic urticaria treated with tacrolimus

• Jung HC
• Lee DH
• Park HS
• Lee HJ
• Kwon JW

• KMID: 1803549
• DOI: http://doi.org/10.4168/aard.2014.2.5.391

Abstract

Cyclosporine is a calcineurin inhibitor which is used to treat antihistamine-resistant chronic urticaria. Unfortunately, some patients cannot use cyclosporine due to its side effects. Tacrolimus is another calcineurin inhibitor with a slightly different side effect profile from that of cyclosporine, and a few cases of chronic urticaria have been treated with tacrolimus. Here, we report a patient with anti-histamine-resistant chronic urticaria, who could not be treated with cyclosporine, due to side effects, but was controlled successfully with tacrolimus. To the best of our knowledge, this is the first report of tacrolimus-treated chronic urticaria in Korea.

Keyword

Urticaria; Tacrolimus; Cyclosporine

MeSH Terms

Calcineurin
Cyclosporine
Humans
Korea
Tacrolimus*
Urticaria*
Calcineurin
Cyclosporine
Tacrolimus

Figure

• 

  Fig. 1. Visual analogue scale (VAS) and medications.

Reference

References

1. Lee SY, Song WJ, Jung JW, Park HW, Cho SH, Min KU, et al. Thyroid autoantibodies and the prognosis of chronic idiopathic urticaria. Allergy Asthma Respir Dis. 2013; 1:151–6.

2. Lee JH. Chronic idiopathic urticaria and antithyroid autoantibodies. Allergy Asthma Respir Dis. 2013; 1:103–4.

3. Choi JH, Ahn IS, Lee HB, Kim HO, Park CW, Lee CH. A study of an autologous serum skin test and helicobacter pylori infection in patients with chronic idiopathic urticaria. Korean J Dermatol. 2009; 47:798–802.

4. Jáuregui I, Ferrer M, Montoro J, Davila I, Bartra J, del Cuvillo A, et al. An-tihistamines in the treatment of chronic urticaria. J Investig Allergol Clin Immunol. 2007; 17(Suppl 2):41–52.

5. Zuberbier T. A summary of the new International EAACI/GA2LEN/EDF/WAO guidelines in urticaria. World Allergy Organ J. 2012; 5(Suppl 1):S1–5.

6. Kim MJ, Kim HS, Kim HO, Park YM. The efficacy, safety and longterm effect of cyclosporine for treating chronic idiopathic urticaria. Korean J Dermatol. 2009; 47:759–64.

7. Kim BS, Jang HS, Jang BS, Kim MB, Oh CK, Kwon KS, et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Korean J Dermatol. 2005; 43:1053–9.

8. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, et al. Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol. 2000; 143:365–72.

9. Trojan TD, Khan DA. Calcineurin inhibitors in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012; 12:412–20.

10. Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol. 2005; 52:145–8.

11. Marsland AM, Soundararajan S, Joseph K, Kaplan AP. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005; 35:554–9.

12. Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2012; 4:326–31.